Three upstate New York companies are developing and launching medical-device innovations, according to the not-for-profit trade association MedTech (medtech.org), which is comprised of Upstate New York technology manufacturers, research institutions, and allied professional services and economic development organizations. The companies are InfiMed, AngioDynamics and Welch Allyn.

InfiMed, Liverpool, N.Y., (infimed.com) announced its fourth generation of digital radiography imaging technology, i4 DR, designed to provide enhanced image quality while reducing the amount of radiation that patients and medical staff are exposed to during X-ray procedures. I4 DR interfaces with a variety of flat panel detectors, including next generation flat panel detectors, and it works through a recently developed technology called InfiVision Automatic Image Enhancement software. The technology's one-click image processing results in greater efficiency by providing the best image quality on the first shot. The same technology is also used for InfiMed's medical imaging platform, called i5. The i5 also increases efficiencies in medical settings by supporting multiple modalities and detectors all from a single system, as well as adaptability to work with next generation technologies. In addition, the i5 offers users flexibility with the ability to integrate with other devices and a customizable workflow for faster patient throughput. The i5 is the first universal medical imaging system available in the market.

AngioDynamics, Queensbury, NY, (angiodynamics.com) a provider of medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease, is in clinical trials for its NanoKnife IRE System. The system is designed to eliminate targeted soft tissue without damaging surrounding structures such as nerves and blood vessels. Using irreversible electroporation (IRE), the NanoKnife IRE System eliminates soft tissue lesion cells while leaving surrounding structures functional. During the minimally invasive IRE procedure, imaging is used to guide the placement of two or more small disposable electrodes. These electrodes then deliver a brief series of intense electric pulses directly into targeted soft tissue cells. Each pulse takes less than 100 millionths of a second. Soft tissue lesion cells are ablated almost instantly, while surrounding structures remain intact. In addition to FDA approval, the company is pursuing two specific therapeutic approvals. The first of these will be for prostate cancer.

Welch Allyn, Skaneateles Falls, NY, (welchallyn.com) manufacturer of medical diagnostic equipment and a range of digital and connected solutions, is developing a suite of products that will feature “plug and play” architecture for medical devices and interoperability with electronic health records and other industry partners. In order to address staffing shortages, time-constraints and changing usage trends in the global healthcare community, the architecture will feature remotely serviceable and connected devices that are easy to use, modular and mobile.

Get Your ‘Edge’

The Medical Edge e-newsletter is your source for the latest on medical engineering and medical devices.
For your FREE subscription, visit
http://medicaldesign.com/subscribe/newsletters/